홈PRGO • NYSE
add
페리고
전일 종가
$24.39
52주 변동폭
$23.89 - $33.96
시가총액
33.26억 USD
평균 거래량
130.24만
주가수익률
-
배당수익률
4.53%
기본 거래소
NYSE
재무
손익계산서
수익
순이익
(USD) | 2024년 9월info | 전년대비 변동 |
---|---|---|
수익 | 10.88억 | -3.23% |
운영비 | 2.91억 | -12.72% |
순이익 | -2100.00만 | -247.89% |
순이익률 | -1.93 | -253.17% |
주당 수익 | 0.81 | 26.56% |
EBITDA | 1.96억 | 15.93% |
유효 세율 | 180.73% | — |
대차대조표
총자산
총부채
(USD) | 2024년 9월info | 전년대비 변동 |
---|---|---|
현금 및 단기 투자 | 14.62억 | 144.39% |
총자산 | 112.03억 | 4.14% |
총부채 | 66.37억 | 10.25% |
총자기자본 | 45.66억 | — |
발행 주식 | 1.36억 | — |
주가순자산비율 | 0.73 | — |
총자산이익률 | 2.63% | — |
자본이익률 | 3.09% | — |
현금 흐름
순현금흐름
(USD) | 2024년 9월info | 전년대비 변동 |
---|---|---|
순이익 | -2100.00만 | -247.89% |
영업 현금 흐름 | 4220.00만 | -66.10% |
투자 현금 흐름 | 2.13억 | 792.83% |
자금 조달 현금 흐름 | 6.53억 | 1,608.78% |
순현금흐름 | 9.21억 | 2,036.19% |
잉여 현금 흐름 | 2.20억 | 174.19% |
정보
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
CEO
설립
1887
웹사이트
직원 수
9,140